Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India · Delayed Price · Currency is INR 130.00
+7.70 (6.30%)
At close: Sep 8, 2025
NSE:ARISTO Revenue
In the fiscal year ending March 31, 2025, Aristo Bio-Tech and Lifescience had annual revenue of 3.18B INR with 29.76% growth. Aristo Bio-Tech and Lifescience had revenue of 1.04B in the half year ending March 31, 2025, with 17.08% growth.
Revenue
3.18B
Revenue Growth
+29.76%
P/S Ratio
0.28
Revenue / Employee
48.20M
Employees
66
Market Cap
885.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.18B | 729.45M | 29.76% |
| Mar 31, 2024 | 2.45B | 272.92M | 12.53% |
| Mar 31, 2023 | 2.18B | 520.92M | 31.43% |
| Mar 31, 2022 | 1.66B | -14.55M | -0.87% |
| Mar 31, 2021 | 1.67B | -340.13M | -16.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Hindustan Unilever | 639.28B |
| Infosys | 1,672.76B |